Xencor Gets Milestone Payment From Merck
socalTECH
APRIL 10, 2014
Monrovia-based biopharmaceuticals developer Xencor reports this morning that it has received a milestone payment from Merck, for the initiation of a Phase 1 clinical trail which uses its antibody engineering technology. Size of that milestone payment was not announced. READ MORE>>.
Let's personalize your content